Biobank of Samples From Patients With Infectious Diseases

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2031

Study Completion Date

January 1, 2031

Conditions
Infectious Diseases
Interventions
OTHER

Sampling

"Additional biological sampling at the same time as routine-care samples taken in the context of the diagnosis of the infectious disease and if planned at one and 12 months of follow-up~* The considered samples are as follows :~ * Blood sample tubes (5 x 5 mL tubes, i.e. 25 mL)~ * Infection site sample if applicable :~* Urine (10 mL)~* Stool (1 mL)~* CSF (1 mL)~* Sputum (1 mL) or bronchoalveolar lavage fluid (10 mL)~* Nasopharyngeal swab (one swab)~* Genital swab (one swab)~* Skin swab (one swab)~* Biopsy (a fragment of a lung, kidney or brain biopsy, if performed)"

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06722131 - Biobank of Samples From Patients With Infectious Diseases | Biotech Hunter | Biotech Hunter